OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Facebook

RSS

Youtube

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

February, 2025

Blog

Andrea Necchi: All you need to know about TAR-200

Andrea Necchi/LinkedIn

Jan 16, 2025, 22:31

Andrea Necchi: All you need to know about TAR-200

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared on LinkedIn:

“All you need to know about TAR-200

Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer – ScienceDirect

Authors: Siamak Daneshmand D., Ashish M. Kamat, Neal D. Shore, Joshua J. Meeks, Matthew D. Galsky, Joseph M. Jacob, Michiel S. van der Heijden, Stephen B. Williams, Thomas Powles, Sam S. Chang, James W.F. Catto, Sarah P. Psutka, Félix Guerrero-Ramos, Evanguelos Xylinas, Makito Miyake, Giuseppe Simone, Karen Daniel, Hussein Sweiti, Christopher Cutie, Andrea Necchi.”

Andrea Necchi Ashish M. Kamat cancer Christopher Cutie Evanguelos Xylinas Félix Guerrero-Ramos Giuseppe Simone Hussein Sweiti James W.F. Catto Joseph M. Jacob Joshua J. Meeks Karen Daniel Makito Miyake Matthew D. Galsky Michiel S. Van der Heijden Neal D. Shore OncoDaily Oncology Sam S. Chang Sarah P. Psutka Siamak Daneshmand D. Stephen B. Williams Thomas Powles

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer